CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
VACCELERATE is a European initiative aimed at accelerating phase 2 and 3 clinical trials for COVID-19 vaccines. It connects stakeholders, enhances trial site capacity, and standardizes protocols to improve vaccine development and response to future pandemics.
The ongoing COVID-19 pandemic creates an unprecedented burden worldwide.
Vaccine-induced immunity is the only promising solution.
There is continued need for phase 2 & 3 vaccine trials to reach long-term, large-scale immunity of the entire European population.VACCELERATE will be the pan-European backbone accelerating phase 2 & 3 COVID-19 vaccine trials.
The overall objective of VACCELERATE is to connect all European stakeholders involved in vaccine development to provide a pan-European platform…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
BIOMEDICAL RESEARCH CENTER OF THE SLOVAK ACADEMY OF SCIENCES
Slovakia, Bratislava
Type: Research institute
Activity type: Research Organisations
SME: No
Portugal, PORTO
Type: Public body
Activity type: Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
SME: No
Center for Clinical Epidemiology and Outcomes Research
Greece, NEO PSICHIKO
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
